In this interview with The Analytical Scientist, CEO Gordon Hamilton talks about the innovations behind our flagship Depixus MAGNA One™ instrument that make magnetic force spectroscopy (MFS) scalable and accessible for the first time, and how it can deliver novel insights with the potential to transform our understanding of health and disease.

Gordon says, “As we continue the commercial roll-out of Depixus MAGNA One, I’m excited to get the instrument system into people’s hands and see what they will do with such a powerful and versatile technology. We hope that MAGNA One will play an important role in the discovery and development of new medicines that will change people’s lives.”

Read the full article at The Analytical Scientist.